Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of TURB and Escalated M-VAC for Bladder Preservation
NCT00003640Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Sep 1998
- Primary completion
- Nov 2000
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, vinblastine, doxorubicin, cisplatin in bladder cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Sep 1998; status: terminated.
02
Drugs
methotrexatevinblastinedoxorubicincisplatin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00003640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003640.